5 Best Biotech Stocks To Buy According To Hedge Funds

Page 5 of 5

1. Johnson & Johnson (NYSE:JNJ)

Number of Hedge Fund Investors In Q1 2023: 86

Johnson & Johnson (NYSE:JNJ) is one of the oldest healthcare companies in the world. It has several biotechnology subsidiaries such as Janssen Biotech and Momenta Pharmaceuticals. Johnson & Johnson (NYSE:JNJ) was set up in 1886 and it is headquartered in New Brunswick, New Jersey.

Insider Monkey’s March 2023 survey covering 943 hedge funds outlined that 86 had bought the firm’s shares. Johnson & Johnson (NYSE:JNJ)’s largest hedge fund investor is Ken Fisher’s Fisher Asset Management since it owns 6.2 million shares that are worth $967 million.

Follow Johnson & Johnson (NYSE:JNJ)

Disclosure: None. You can also take a look at 15 Stocks Warren Buffett Sold and 25 Countries with the Highest Debt to GDP Ratios.

Follow Insider Monkey on Twitter

Page 5 of 5